Aliment Pharmacol Ther

1. RICCIUTO A, Liu K, El-Matary W, Amin M, et al
   Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
   Aliment Pharmacol Ther. 2024 Mar 10. doi: 10.1111/apt.17936.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. KHAN N, Sundararajan R, Patel M, Trivedi C, et al
   Effectiveness Of Tofacitinib In Ulcerative Colitis Patients: A Nationwide Veterans Administration Cohort study.
   Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002761.
   

   >> Share

   
   
3. DALAL RS, Kallumkal G, Cabral HJ, Barnes EL, et al
   One-Year Comparative Effectiveness of Upadacitinib Versus Tofacitinib For Ulcerative Colitis: A Multicenter Cohort Study.
   Am J Gastroenterol. 2024 Mar 12. doi: 10.14309/ajg.0000000000002746.
   

   >> Share

   
   

   
   BMC Gastroenterol

4. BEHNOUSH AH, Maroufi SP, Reshadmanesh T, Mohtasham Kia Y, et al
   Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis.
   BMC Gastroenterol. 2024;24:107.
   

   >> Share

   
   
5. SHAO Y, Zhao Y, Lv H, Yan P, et al
   Clinical features of inflammatory bowel disease unclassified: a case-control study.
   BMC Gastroenterol. 2024;24:105.
   

   >> Share

   
   

   
   Dig Dis Sci

6. SAHYOUN LC, Fetene J, McMillan C, Protiva P, et al
   Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.
   Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08355.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

7. STEPHENS IJB, Murphy B, Burns L, McCawley N, et al
   Contemporary perioperative outcomes after total abdominal colectomy for ulcerative colitis in a tertiary referral centre.
   Eur J Gastroenterol Hepatol. 2024 Mar 11. doi: 10.1097/MEG.0000000000002755.
   

   >> Share

   
   
8. ROKKAS T, Gisbert JP, Ekmektzoglou K, Dassopoulos T, et al
   Comparative maintenance performance of all biologic agents and small molecules in ulcerative colitis: a network meta-analysis.
   Eur J Gastroenterol Hepatol. 2024 Mar 12. doi: 10.1097/MEG.0000000000002751.
   

   >> Share

   
   
9. FIORINO G, Colombel JF, Katsanos K, Mearin F, et al
   Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in Italy.
   Eur J Gastroenterol Hepatol. 2024 Mar 1. doi: 10.1097/MEG.0000000000002740.
   

   >> Share

   
   

   
   Gastroenterology

10. IACUCCI M, Maeda Y, Ghosh S
    A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
    

    >> Share

    
    

    
    Gut

11. ANANTHAKRISHNAN AN
    Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants?
    Gut. 2024;73:559-560.
    

    >> Share

    
    
12. SCHULZ-KUHNT A, Ruhle K, Javidmehr A, Dobronti M, et al
    ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo.
    Gut. 2024;73:601-612.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

13. 
    Correction to: Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
    Inflamm Bowel Dis. 2024 Mar 14:izae070. doi: 10.1093.
    

    >> Share

    
    
14. ALSOUD D, Van Calster B
    Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Mar 9:izae048. doi: 10.1093.
    

    >> Share

    
    
15. SANDS BE, D'Haens G, Clemow DB, Irving PM, et al
    Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
    Inflamm Bowel Dis. 2024 Mar 9:izae024. doi: 10.1093.
    

    >> Share

    
    

    
    J Crohns Colitis

16. GENG Z, Li J, Zuo L, Zhang X, et al
    Intestinal adipocytes transdifferentiate into myofibroblast-like cells and contribute to fibrosis in Crohn's disease.
    J Crohns Colitis. 2024 Mar 11:jjae036. doi: 10.1093.
    

    >> Share

    
    
17. ZAMAN S, Mohamedahmed AYY, Abdelrahman W, Abdalla HE, et al
    Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
    J Crohns Colitis. 2024 Mar 11:jjae037. doi: 10.1093.
    

    >> Share

    
    
18. LEHMANN M, Weixler B, Elezkurtaj S, Loddenkemper C, et al
    Spatial single cell profiling using imaging mass cytometry - inflammatory versus penetrating Crohn's disease.
    J Crohns Colitis. 2024 Mar 11:jjae033. doi: 10.1093.
    

    >> Share

    
    

    
    Lancet

19. NIELSEN OH, Gubatan JM, Kolho KL, Streett SE, et al
    Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation.
    Lancet. 2024 Mar 5:S0140-6736(24)00052-7. doi: 10.1016/S0140-6736(24)00052.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share